Skip to main content

Table 2 Multivariate analysis of clinical factors associated with Progression-Free Survival and Overall Survival among patients with ESCC

From: Impact of sex on the prognosis of patients with esophageal squamous cell cancer underwent definitive radiotherapy: a propensity score-matched analysis

Variates Progression-Free Survival Overall Survival
HR(95%CI) χ2 p HR(95%CI) χ2 p
gender 0.746 (0.611–0.910) 8.375 0.004 0.755 (0.615–0.926) 7.275 0.007
age 0.997 (0.988–1.006) 0.511 0.475 0.997 (0.988–1.006) 0.470 0.493
location 1.162 (1.031–1.308) 6.095 0.014 1.131 (1.003–1.275) 4.023 0.045
T stage 1.184 (1.029–1.362) 5.547 0.019 1.266 (1.095–1.462) 10.22 0.001
N stage 1.328 (1.013–1.741) 4.219 0.040 1.303 (0.993–1.711) 3.640 0.056
TNM stage 1.236 (1.014–1.506) 4.411 0.036 1.181 (0.965–1.445) 2.601 0.107
RT dose 0.977 (0.954–1.001) 3.631 0.057 0.970 (0.946–0.995) 5.681 0.017
Treatment 0.741 (0.621–0.884) 11.061 0.001 0.712 (0.595–0.852) 13.71 0.000